Nyxoah S.A. is a health-techn company developing solutions for sleep disordered breathing conditions, including severe Obstructive Sleep Apnea, a common condition associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke. Nyxoah was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Name / Ticker | Price | Zen Rating |
---|---|---|
$15.08 | A | |
$10.16 | A | |
$82.93 | B |